EUR 89,40
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 202.
Idioma: Inglés
Publicado por Elsevier Science Health Science, 2018
ISBN 10: 0323554296 ISBN 13: 9780323554299
Librería: Revaluation Books, Exeter, Reino Unido
EUR 83,96
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 1st edition. 192 pages. 9.00x7.25x0.50 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 99,60
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 202.
EUR 100,43
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 202.
Idioma: Inglés
Publicado por Elsevier - Health Sciences Division, 2018
ISBN 10: 0323554296 ISBN 13: 9780323554299
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 99,01
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPaperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.
Idioma: Inglés
Publicado por Elsevier Health Sciences, 2018
ISBN 10: 0323554296 ISBN 13: 9780323554299
Librería: preigu, Osnabrück, Alemania
EUR 84,95
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Stroke Prevention in Atrial Fibrillation | Greg Flaker | Buch | Englisch | 2018 | Elsevier Health Sciences | EAN 9780323554299 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 83,04
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Elsevier Health Sciences Jun 2018, 2018
ISBN 10: 0323554296 ISBN 13: 9780323554299
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 89,99
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today's available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients. Covers a broad spectrum of management and treatment options for atrial fibrillation including anticoagulants, surgical and implanted devices. Presents information on recent drug trials to keep you up to date with the latest developments. Includes guidance on anticoagulation in special situations, such as cardioversion and ablation, in addition to atrial fibrillation treatment in patients with other medical conditions including cancer, major bleeding disorders, and renal or liver disease. Chapter on Risk Stratification assists in identifying patients with a high risk of stroke and predicting treatment outcomes. Chapter on The New Anticoagulation Clinic overviews best practices for patient education, compliance, follow-up monitoring, and quality assurance to aid in better patient outcomes. 202 pp. Englisch.
Idioma: Inglés
Publicado por Elsevier Health Sciences, 2018
ISBN 10: 0323554296 ISBN 13: 9780323554299
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 100,24
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today's available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients. Covers a broad spectrum of management and treatment options for atrial fibrillation including anticoagulants, surgical and implanted devices. Presents information on recent drug trials to keep you up to date with the latest developments. Includes guidance on anticoagulation in special situations, such as cardioversion and ablation, in addition to atrial fibrillation treatment in patients with other medical conditions including cancer, major bleeding disorders, and renal or liver disease. Chapter on Risk Stratification assists in identifying patients with a high risk of stroke and predicting treatment outcomes. Chapter on The New Anticoagulation Clinic overviews best practices for patient education, compliance, follow-up monitoring, and quality assurance to aid in better patient outcomes.